Finasteride 1 mg (Finpecia) Tablets
Finpecia Tablet contains Finasteride 1 mg, a 5-alpha reductase inhibitor indicated for the management of androgenetic alopecia (male pattern hair loss) in adult men. The medication helps slow the progression of hair loss while promoting hair regrowth in affected areas, particularly the vertex and mid-scalp. It works by lowering scalp levels of dihydrotestosterone (DHT), the androgen primarily responsible for follicular miniaturization and progressive hair thinning.
For optimal therapeutic outcomes, Finpecia should be taken orally once daily, with or without food, exactly as prescribed by your healthcare provider. The tablet should be swallowed whole without crushing or chewing. Since visible improvement in hair growth generally requires several months of continuous treatment, consistent daily use is recommended. Do not discontinue therapy prematurely without consulting your physician, as stopping treatment may gradually reverse the benefits achieved.
Although Finpecia is generally well tolerated, some individuals may experience adverse effects, most commonly related to sexual function. These include decreased libido, erectile dysfunction, and ejaculation disorders. Hypersensitivity reactions, including rash, pruritus, or swelling of the lips and face, have also been reported. Patients experiencing persistent or severe adverse reactions should seek prompt medical attention.
Before initiating treatment, inform your healthcare provider about all prescription medications, over-the-counter drugs, herbal supplements, or underlying medical conditions to minimize the risk of potential drug interactions or complications.
Therapeutic Uses
- Management of androgenetic alopecia (male pattern hair loss)
- Treatment of benign prostatic hyperplasia (as prescribed by a healthcare professional)
Benefits
Management of Hair Loss
Finpecia helps reduce progressive hair thinning by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), thereby protecting susceptible hair follicles from miniaturization. Regular treatment supports hair retention, stimulates regrowth in appropriate candidates, and may improve hair density over time. Continued therapy is necessary to maintain clinical benefits.
Management of Benign Prostatic Hyperplasia
In patients with benign prostatic hyperplasia (BPH), Finasteride decreases DHT levels, leading to a gradual reduction in prostate volume. This action helps relieve urinary symptoms associated with prostate enlargement, including reduced urinary flow, increased urinary frequency, and difficulty initiating urination.
Possible Side Effects
Most adverse effects are mild and tend to resolve with continued therapy. However, medical advice should be sought if symptoms persist or worsen.
Common adverse effects include:
- Decreased libido
- Erectile dysfunction
- Ejaculatory disorders
Directions for Use
Administer Finpecia exactly as directed by your healthcare provider. The tablet may be taken with or without meals but should preferably be taken at the same time each day to maintain consistent therapeutic levels. Swallow the tablet whole without breaking, crushing, or chewing.
Mechanism of Action
Finpecia contains Finasteride, a selective Type II 5-alpha reductase inhibitor. By blocking the enzymatic conversion of testosterone into dihydrotestosterone (DHT), it reduces DHT concentrations in the scalp and prostate. Lower DHT levels help preserve hair follicles, promote hair regrowth in androgenetic alopecia, and reduce prostate enlargement in patients with benign prostatic hyperplasia.